Thomas Wagner

857 total citations
50 papers, 503 citations indexed

About

Thomas Wagner is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas Wagner has authored 50 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 18 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas Wagner's work include Testicular diseases and treatments (28 papers), Sexual Differentiation and Disorders (15 papers) and Sarcoma Diagnosis and Treatment (10 papers). Thomas Wagner is often cited by papers focused on Testicular diseases and treatments (28 papers), Sexual Differentiation and Disorders (15 papers) and Sarcoma Diagnosis and Treatment (10 papers). Thomas Wagner collaborates with scholars based in Denmark, United Kingdom and Germany. Thomas Wagner's co-authors include Gedske Daugaard, Jakob Lauritsen, Michael Kreiberg, Mikkel Bandak, James J. Stark, Mads Agerbæk, Peter M. Wehmeier, Rodrigo Escobar, Alexander Schacht and Daniel M. Berney and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Thomas Wagner

47 papers receiving 498 citations

Peers

Thomas Wagner

SURGE

ONCOL

PRM

PPCH

Penelope Trimpou Sweden

Liang Zhou China

Chongqi Jia China

Zhengyan Tang China

Penelope J. Robinson Australia

Yuki Shiko Japan

Yael Levy‐Shraga Israel

Kenichi Kano Japan

Faruk Alagöl Türkiye

Ming-Ping Wu Taiwan

Penelope Trimpou Sweden

Thomas Wagner

256 ×1.1

SURGE

96 ×1.2

80 ×1.1

ONCOL

59 ×0.8

PRM

32 ×0.6

PPCH

Citations per year, relative to Thomas Wagner Thomas Wagner (= 1×) peers Penelope Trimpou

Countries citing papers authored by Thomas Wagner

Since Specialization

Citations

This map shows the geographic impact of Thomas Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wagner more than expected).

Fields of papers citing papers by Thomas Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wagner. The network helps show where Thomas Wagner may publish in the future.

Co-authorship network of co-authors of Thomas Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Wagner. A scholar is included among the top collaborators of Thomas Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Wagner. Thomas Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bremmer, Felix, Fleur Webster, Gedske Daugaard, et al.. (2025). Second edition ICCR dataset for testicular germ cell tumours: a reporting guide for histopathological diagnosis of orchiectomy specimens. Histopathology. 88(1). 252–264. 1 indexed citations

Lauritsen, Jakob, et al.. (2025). Relapse detection in the Danish surveillance program of patients with clinical stage I seminoma: a nationwide study. Acta Oncologica. 64. 191–199. 1 indexed citations

Daugaard, Gedske, Mikkel Bandak, Mads Agerbæk, et al.. (2024). Use of Risk Factors To Select Adjuvant Therapy Versus Surveillance for Testicular Nonseminoma and Seminoma Germ Cell Tumors. European Urology Focus. 10(3). 359–360. 1 indexed citations

Boormans, Joost L., Richard Sylvester, Lynn Anson‐Cartwright, et al.. (2023). Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office. European Urology Oncology. 7(3). 537–543. 9 indexed citations

Jørgensen, Poul, Michael Kreiberg, Niels Jørgensen, et al.. (2023). Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors – results from a randomized double-blind trial. Acta Oncologica. 62(7). 689–695. 2 indexed citations

Bandak, Mikkel, Michael Kreiberg, Thomas Wagner, et al.. (2023). Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer. JNCI Journal of the National Cancer Institute. 115(6). 753–756. 1 indexed citations

Boormans, Joost L., Richard Sylvester, Lynn Anson‐Cartwright, et al.. (2023). European Association of Urology (EAU) Testicular Cancer Guidelines Panel: A new prognostic factor risk group classification for patients with clinical stage 1 seminoma in active surveillance.. Journal of Clinical Oncology. 41(6_suppl). 410–410. 2 indexed citations

Wagner, Thomas, Birgitte Grønkær Toft, Jakob Lauritsen, et al.. (2023). Prognostic factors for relapse in patients with clinical stage I testicular seminoma: A nationwide, population-based cohort study.. Journal of Clinical Oncology. 41(16_suppl). 5041–5041. 1 indexed citations

Kreiberg, Michael, Niels Jørgensen, Anders Juul, et al.. (2022). A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention). Clinical Genitourinary Cancer. 20(5). 404–414. 4 indexed citations

10.

Chovanec, Michal, Jakob Lauritsen, Mikkel Bandak, et al.. (2021). Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nature Reviews Urology. 18(4). 227–245. 51 indexed citations

11.

Bandak, Mikkel, Allan Jensen, Christian Dehlendorff, et al.. (2021). Paternity After Treatment for Testicular Germ Cell Cancer: A Danish Nationwide Population-Based Cohort Study. JNCI Journal of the National Cancer Institute. 114(1). 149–155. 7 indexed citations

12.

Daugaard, Gedske, Thomas Wagner, Katarzyna Jóźwiak, et al.. (2020). Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: A systematic review and meta-analysis. European Urology Open Science. 19. e401–e402. 1 indexed citations

13.

Lauritsen, Jakob, Mikkel Bandak, Michael Kreiberg, et al.. (2020). Long-term neurotoxicity and quality of life in testicular cancer survivors—a nationwide cohort study. Journal of Cancer Survivorship. 15(4). 509–517. 17 indexed citations

14.

Scandura, Glenda, Thomas Wagner, Luis Beltrán, et al.. (2020). Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?. Modern Pathology. 34(4). 834–841. 3 indexed citations

15.

Jacobs, Jeffrey, Thomas Wagner, Chuanhong Liao, et al.. (2019). Impact of Angiotensin II Signaling Blockade on Clinical Outcomes in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 64(7). 1938–1944. 30 indexed citations

16.

Haußmann, Robert, et al.. (2016). Beurteilung der Fahrtauglichkeit bei Patienten mit MCI und demenziellen Syndromen. Der Nervenarzt. 88(3). 247–253. 4 indexed citations

17.

Wagner, Thomas, et al.. (2014). Assessment of personal resources for safe driving. The principles of medical psychological assessment in Germany. 4 indexed citations

18.

Escobar, Rodrigo, Alexander Schacht, Peter M. Wehmeier, & Thomas Wagner. (2010). Quality of Life and Attention-Deficit/Hyperactivity Disorder Core Symptoms. Journal of Clinical Psychopharmacology. 30(2). 145–151. 20 indexed citations

19.

Brown, Melissa M., et al.. (2006). Pain and suffering disability index. Current Opinion in Ophthalmology. 17(3). 292–297.

20.

Decruyenaere, Johan, et al.. (2005). 90-DAY FOLLOW-UP OF PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED) (DAA) FOR SEVERE SEPSIS: A BELGIAN OPEN LABEL STUDY.. Critical Care Medicine. 33. A10–A10. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact